Liege, Belgium, 10 December 2020 – 20:30 CET – With reference to the two press releases issued on 10 December 2020 at 08:00 and 17:30 CET respectively, Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the “Company” or “Mithra”), a company dedicated to women’s health, announces the final terms of the offering (the “Offering”) of EUR 125 million senior unsecured convertible bonds due 17 December 2025 (the “Bonds”).
Share it
Latest news
Mithra reaches milestone in estetrol skin study
8 April 2024
Mithra updates on its ongoing monetization process
28 March 2024